Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

UCSD researchers report fundamental breakthrough in treating, preventing shock

Feb. 18, 2000

Promising new atherosclerosis treatment expected to enter clinical trials later this year

Feb. 18, 2000

Acute and subchronic testing in mice indicates limited systemic toxicity for GLG-V-13

Feb. 17, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Guanylate cyclase-activating agents in early development at Aventis

Feb. 17, 2000

Alexion and Brigham & Women's Hospital to develop novel antiinflammatory antibody

Feb. 17, 2000

Novel gene therapy reverses atherosclerotic process in mice

Feb. 17, 2000

German researchers disclose new agents for hypertension

Feb. 16, 2000

FDA grants Merck & Co. marketing exclusivity extension for Vasotec

Feb. 16, 2000

Potent and selective ETA antagonist selected as development candidate

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...